Ivermectin, science and influence peddling: is the French state trying to cover up the case?
Interview with Sylvain Rousselot, psychotherapist, who asked Inserm (National Institute of Health and Medical Research) for the scientific correspondence of one of its agents, Dominique Costagliola, with a British researcher, Andrew Hill. Both have been working on a covid-19 drug candidate, ivermectin, a cheap drug that has fallen into the